nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Atabay EK, Mecca C, Wang Q, et al. Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. Blood. 2022;139(5):717-731.
|
|
|
|
140 |
7 |
p. 794 |
artikel |
2 |
DDX41: the poster child for familial AML
|
Rio‐Machin, Ana |
|
|
140 |
7 |
p. 667-669 |
artikel |
3 |
Editorial Board
|
|
|
|
140 |
7 |
p. i |
artikel |
4 |
Four decades of progress
|
Cavazzana, Marina |
|
|
140 |
7 |
p. 665-666 |
artikel |
5 |
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
|
El Chaer, Firas |
|
|
140 |
7 |
p. 673-684 |
artikel |
6 |
Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders
|
La, Jennifer |
|
|
140 |
7 |
p. 782-785 |
artikel |
7 |
Isn't it ironic: better RBCs by blocking iron
|
Parrow, Nermi L. |
|
|
140 |
7 |
p. 669-670 |
artikel |
8 |
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC
|
Cuvelier, Geoffrey D.E. |
|
|
140 |
7 |
p. 685-705 |
artikel |
9 |
Outcomes for adenosine deaminase–deficient SCID
|
|
|
|
140 |
7 |
p. 795 |
artikel |
10 |
Prevalence of neuropsychiatric symptoms and stroke in patients with hereditary thrombotic thrombocytopenic purpura
|
Borogovac, Azra |
|
|
140 |
7 |
p. 785-789 |
artikel |
11 |
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
|
Duployez, Nicolas |
|
|
140 |
7 |
p. 756-768 |
artikel |
12 |
Quercetin ameliorates XIAP deficiency–associated hyperinflammation
|
Chiang, Samuel C.C. |
|
|
140 |
7 |
p. 706-715 |
artikel |
13 |
Sounding the alarm for prophylaxis in hTTP
|
Mazepa, Marshall |
|
|
140 |
7 |
p. 671-672 |
artikel |
14 |
Splenic diffuse red pulp small B-cell lymphoma with cyclin D3 expression
|
Ozkaya, Neval |
|
|
140 |
7 |
p. 793 |
artikel |
15 |
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms
|
Li, Peng |
|
|
140 |
7 |
p. 716-755 |
artikel |
16 |
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease
|
Nyffenegger, Naja |
|
|
140 |
7 |
p. 769-781 |
artikel |
17 |
Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience
|
Fattizzo, Bruno |
|
|
140 |
7 |
p. 789-792 |
artikel |
18 |
Vats R, Kaminski TW, Ju E-M, et al. P-selectin deficiency promotes liver senescence in sickle cell disease mice. Blood. 2021;137(19):2676-2680.
|
|
|
|
140 |
7 |
p. 794 |
artikel |